A detailed history of Rhumbline Advisers transactions in Organon & Co. stock. As of the latest transaction made, Rhumbline Advisers holds 525,157 shares of OGN stock, worth $7.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
525,157
Previous 527,829 0.51%
Holding current value
$7.74 Million
Previous $10.9 Million 8.05%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$18.65 - $23.03 $49,832 - $61,536
-2,672 Reduced 0.51%
525,157 $10 Million
Q2 2024

Aug 01, 2024

SELL
$17.45 - $21.96 $284,644 - $358,211
-16,312 Reduced 3.0%
527,829 $10.9 Million
Q1 2024

May 09, 2024

SELL
$13.78 - $18.8 $458,818 - $625,964
-33,296 Reduced 5.77%
544,141 $10.2 Million
Q4 2023

Feb 08, 2024

BUY
$10.95 - $17.32 $1.4 Million - $2.22 Million
128,001 Added 28.48%
577,437 $8.33 Million
Q3 2023

Nov 09, 2023

SELL
$16.59 - $23.77 $105,910 - $151,747
-6,384 Reduced 1.4%
449,436 $7.8 Million
Q2 2023

Aug 08, 2023

SELL
$19.27 - $24.63 $107,141 - $136,942
-5,560 Reduced 1.21%
455,820 $9.49 Million
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $302,236 - $452,648
14,110 Added 3.15%
461,380 $10.9 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $386,712 - $474,639
16,590 Added 3.85%
447,270 $12.5 Million
Q3 2022

Nov 10, 2022

BUY
$23.4 - $34.25 $412,776 - $604,170
17,640 Added 4.27%
430,680 $10.1 Million
Q2 2022

Aug 11, 2022

BUY
$31.66 - $38.9 $1.38 Million - $1.69 Million
43,573 Added 11.79%
413,040 $13.9 Million
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $626,661 - $810,028
-20,580 Reduced 5.28%
369,467 $12.9 Million
Q4 2021

Feb 10, 2022

BUY
$28.67 - $37.13 $252,640 - $327,189
8,812 Added 2.31%
390,047 $11.9 Million
Q3 2021

Nov 12, 2021

SELL
$28.63 - $35.64 $105,472 - $131,297
-3,684 Reduced 0.96%
381,235 $12.5 Million
Q2 2021

Aug 05, 2021

BUY
$28.45 - $38.0 $11 Million - $14.6 Million
384,919 New
384,919 $11.6 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.